A CLINICAL TRIAL TO STUDY THE EFFECTS OF TWO DRUGS, BUPIVACAINE AND LEVOBUPIVACAINE IN GYNAECOLOGICAL PATIENTS UNDERGOING SPINAL ANAESTHESIA
Phase 2
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2023/07/055667
- Lead Sponsor
- Department of Anaesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients belonging to ASA I and II
Exclusion Criteria
Patients with significant cardiac,pulmonary, hepatic or renal disease
Spinal deformities
Abnormal coagulation profile (INR 1.5)
Evidences of skin infections at the site of injection
Disabling neuropsychiatric disorders
Known hypersensitivity to bupivacaine, levobupivacaine or fentanyl
Chronic drug abusers
Alcoholics
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the onset of sensory block in both groups <br/ ><br>To measure the duration of sensory block in both groups <br/ ><br>To measure highest level of sensory block in both groups <br/ ><br>To measure the onset of motor block in both groups <br/ ><br>To measure the duration of motor block in both groups <br/ ><br>To find out the changes in heart rate & mean arterial blood pressure during the course of spinal anaesthesiaTimepoint: Every three minutes interval
- Secondary Outcome Measures
Name Time Method To compare if hyperbaric levobupivacaine is a safer alternative to hyperbaric bupivacaine for elective gynaecological surgeries in subarachnoid blockTimepoint: After completion of surgery, wearing of effects of spinal anaesthesia